Natroba (spinosad) Topical Suspension 0.9%

About ParaPRO

ParaPRO is a U.S.-based commercial-stage biotech company addressing parasitic infestations with its lead product, Natroba™ (spinosad) Topical Suspension 0.9%, a prescription treatment for head lice. The company's strategy is built on commercializing the unique spinosad compound, for which it holds a license from Eli Lilly/Corteva, and supporting the professional community with educational resources. It operates as a lean, privately held organization targeting a niche but persistent market with a significant need due to growing resistance to older therapies. ParaPRO's outlook is tied to the sustained commercial performance of Natroba and potential expansion of its spinosad-based portfolio.

Therapeutic Areas